Osimertinib as first-line treatment of EGFR mutant advanced non-small-cell lung cancer

Translational Lung Cancer Research ◽

10.21037/tlcr.2017.10.10 ◽

2017 ◽

Vol 6 (S1) ◽

pp. S62-S66 ◽

Author(s):

Chong-Kin Liam

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

Apatinib plus gefitinib as first-line treatment in advanced EGFR-mutant non-small cell lung cancer: the phase III ACTIVE study (CTONG1706)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.05.006 ◽

2021 ◽

Author(s):

Hongyun Zhao ◽

Wenxiu Yao ◽

Xuhong Min ◽

Kangsheng Gu ◽

Guohua Yu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

First-Line Treatment in EGFR Mutant Non-Small Cell Lung Cancer: Is There a Best Option?

Frontiers in Oncology ◽

10.3389/fonc.2018.00094 ◽

2018 ◽

Vol 8 ◽

Author(s):

Ajaz Bulbul ◽

Hatim Husain

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706)

Cancer Communications ◽

10.1186/s40880-019-0414-4 ◽

2019 ◽

Vol 39 (1) ◽

Author(s):

Zhonghan Zhang ◽

Fan Luo ◽

Yang Zhang ◽

Yuxiang Ma ◽

Shaodong Hong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Study Protocol ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride

Case Medical Research ◽

10.31525/ct1-nct03890055 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Phase I Study of Apatinib in Combination with Gefitinib As First-Line Treatment in Patients with EGFR-Mutant Advanced Non-Squamous Non-Small Cell Lung Cancer

SSRN Electronic Journal ◽

10.2139/ssrn.3454715 ◽

2019 ◽

Author(s):

Zhonghan Zhang ◽

Yang Zhang ◽

Fan Luo ◽

Yuxiang Ma ◽

Wenfeng Fang ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Phase I Study ◽

Line Treatment ◽

Small Cell Lung ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

Real-world outcomes for patients with metastatic non-small cell lung cancer according to first-line treatment

Revue d Épidémiologie et de Santé Publique ◽

10.1016/j.respe.2021.04.057 ◽

2021 ◽

Vol 69 ◽

pp. S36

Author(s):

Y. Belaroussi ◽

S. Cousin ◽

M. Carton ◽

M. Lebitasy ◽

L. Laborde ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Crizotinib vs platinum‐based chemotherapy as first‐line treatment for advanced non‐small cell lung cancer with different ROS1 fusion variants

Cancer Medicine ◽

10.1002/cam4.2984 ◽

2020 ◽

Vol 9 (10) ◽

pp. 3328-3336 ◽

Author(s):

Haiyan Xu ◽

Quan Zhang ◽

Li Liang ◽

Junling Li ◽

Zhefeng Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

Platinum Based Chemotherapy ◽

First Line Treatment

Download Full-text

Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamous non-small cell lung cancer

Translational Cancer Research ◽

10.21037/tcr.2019.12.57 ◽

2019 ◽

Vol 8 (8) ◽

pp. E11-E14

Author(s):

Teppei Yamaguchi ◽

Toyoaki Hida

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

Expert Review of Anticancer Therapy ◽

10.1586/era.09.3 ◽

2009 ◽

Vol 9 (4) ◽

pp. 425-435 ◽

Author(s):

Marcello Tiseo ◽

Marco Bartolotti ◽

Francesco Gelsomino ◽

Andrea Ardizzoni

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

Histologic Subtype ◽

First Line Treatment

Download Full-text

Clinical effect of erlotinib as first-line treatment for Asian elderly patients with advanced non-small-cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1450-6 ◽

2010 ◽

Vol 67 (2) ◽

pp. 475-479 ◽

Author(s):

Xin-Hua Xu ◽

Jin Su ◽

Xiang-Yang Fu ◽

Feng Xue ◽

Qiao Huang ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Clinical Effect ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text